Eric Swayze, EVP Research at IONIS PHARMACEUTICALS INC (IONS), sold 14,330 shares at $32.84 ($471K) on 2025-01-16, disclosed to the SEC on 2025-01-17.
Seasonal sale ($471k) by EVP Research — this insider has traded IONS in January in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.70 | 22 | $719 | 0.2% |
| 2 | $32.84 | 7,154 | $235K | 49.9% |
| 3 | $32.84 | 7,154 | $235K | 49.9% |
| Total | $32.84 avg | 14,330 | $471K | 100% |
| Filing → |
| IONS | SELL | 2026-02-02 | $512K | — | Filing → |
| IONS | SELL | 2026-01-20 | $748K | — | Filing → |
| IONS | SELL | 2026-01-06 | $1.9M | — | Filing → |